TenNor Therapeutics Ltd   Report issue

For profit Phase 2 Phase 3
Founded: Westfield NJ United States (2013)

Organization Overview

First Clinical Trial
2016
NCT06178718
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

TenNor | TenNor Therapeutics Limited | TenNor Therapeutics (Suzhou) Limited

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacterial Infections (Phase 2)

Communicable Diseases (Phase 2)

Gram-Positive Bacterial Infections (Phase 2)

Infections (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 11
  • # of Trial APIs: 7